Introduction to Substance Use Disorder

Registration Fee: Non FL Chapter Member $40

Speaker: Jason Peklinsky, MD

Disclosure Information:
FAFP Disclosure and Mitigation of Relevant Financial Relationships
It is the policy of the Florida Academy of Family Physicians (FAFP) to ensure that Accredited Continuing Education (ACE) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the FAFP requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. If there are identified relevant financial relationships, these must be mitigated, in accordance with the FAFP’s policies regarding mitigation of relevant financial relationships, prior to the individual’s participation in the development or presentation of ACE content. Any individual who refuses to disclose all financial relationships will be disqualified from involvement in the development, management, presentation, or evaluation of the ACE activity.

This internet enduring material was independently planned by the FAFP Continuing Professional Development Committee. For this educational activity, all planners and faculty have disclosed, and peer review of all educational content was conducted to ensure independence, evidence base, fair balance, and absence of commercial bias.

CPD Committee Disclosure Information
None of the planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Faculty Disclosure Information
Dr. Jason Peklinsky, speaker of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

About the Speaker: Dr. Jason Peklinsky is board certified in Family Medicine and Addiction Medicine. He is a West Virginia native who completed medical school and residency training at West Virginia University's School of Medicine in Morgantown, WV. He served as chief resident before matriculating into a faculty role in the department prior to his departure to the University of South Florida-Morton Plant Mease Family Medicine Residency Program in Clearwater, FL. While Associate Residency Director at WVU, Dr. Peklinsky worked on expanding primary care roles in medication assisted treatment. He worked in collaboration with the Department of Behavioral Medicine and Psychiatry's Comprehensive Opioid Addiction Program as a treatment provider and supported the addiction fellowship programs. He developed a general addiction curriculum for the family medicine residency program that included a comprehensive training track for those interested in addiction medicine fellowship. He also began the integration of treatment of substance use disorders through medication assistance into the family medicine clinic. Ultimately, Dr. Peklinsky supports advocating for the value of full scope of practice in Family Medicine. His role as faculty at USF/MPM continues the journey to support the growth and expansion of student and resident training as well as improve patient care.

Program Information:
Date of Release: June 19, 2023
Expiration Date: June 19, 2026

Target Audience: AAFP/FAFP Members and Non-Member Physicians
Estimated Time to Complete the Activity: 1 hour

Accreditation and Designation Statements:
      
Accreditation Statement:
The Florida Academy of Family Physicians is accredited by the Florida Medical Association to provide continuing medical education for physicians.


Program Overview:
This one-hour webinar meets the Substance Abuse and Mental Health Services Administration (SAMHSA) recommended content related to the prevention, recognition, and care of people with substance use disorders including those with concurrent pain and/or psychiatric and medical co-morbidities.

The United States faces a crisis of deaths from opioids, stimulants, synthetic agents, tobacco and alcohol. These deaths represent a mere fraction of the total number of Americans harmed by substance misuse, and many people suffer daily from chronic use disorders. The long-term effects of substance misuse impact individuals, families, and communities. This is further compounded by changing patterns of substance misuse, as well as an increasing incidence of polysubstance use. The rise in fentanyl use or exposure, concurrent substance misuse, as well as overdose deaths, necessitates consideration of educational elements that promote understanding of SUDs, as well as their identification, treatment, and management.

Federal and state policy over the last decade has sought to overcome the long-term effects of substance misuse impacting individuals, families, communities, and those charged with resource allocation. Section 1263 of the ‘Consolidated Appropriations Act of 2023’ otherwise known as the Medication Access and Training Expansion (MATE) Act, requires new or renewing Drug Enforcement Administration (DEA) registrants, as of June 27, 2023, to have completed a total of at least 8 hours of training on opioid or other substance use disorders.

Learning Objectives:
Upon completion of this activity, learners will be able to:

• Present the new DEA substance use disorder policy changes
• Define the spectrum of substance use disorders and treatment
• Define recovery
• Review screening for substance use disorder
• Introduce the levels of care for substance use disorders

Instructions for Earning Credit:

• Watch and listen to the 1-hour webinar in full until completed.
• Reflect on the current and best practices discussed and how the information may change your own current practices.
• Use the practice cases to challenge your understanding of substance use disorders or clinical practice guidelines.
• Complete the CME Activity Evaluation at the end of the webinar.
• Your CME certificate will be emailed and will be available for printing after you have submitted the activity evaluation. Please keep your certificates for your records and for your DEA and/or state re-licensure requirements. Do not send certificate copies to the FAFP or the AAFP offices.
• CME credits earned from this activity will be reported to AAFP and CE Broker within 30 days, provided you have completed and successfully submitted the evaluation.

Medium or Combination of Media Used: Online webinar
System Requirements to Participate: Computer/internet connection
Website Viewing Requirements:
Internet Explorer 8.0 or later
Mozilla Firefox 25.0 or later
Google Chrome 30.0 or later
Safari 5.0 or later

Educational Content Viewing Requirements:
Mozilla Firefox 25.0 or later
Google Chrome 30.0 or later
Safari 5.0 or later
Adobe Acrobat Reader
Flash Player Plug-In (9.0 or later)
Sound Card & Speakers

Copyright and Intellectual Property
Copyright 2023, FAFP. All rights reserved. No part of this publication may be reproduced or transmitted in any other form or by any other means, electronic or mechanical, without first obtaining written permission from the FAFP.

Information presented at the FAFP CME activities is for education of attendees. Any materials or information displayed during these CME activities are the property of the FAFP and the presenter and should not be photographed, copied, photocopied, transferred to electronic formats, reproduced or distributed without written permission of the FAFP and the presenter.

Any use of FAFP educational content for commercial purposes, which includes but is not limited to oral presentations, audiovisual materials used by speakers and/or program handouts without written consent from the FAFP is prohibited. This policy applies before, during and after each activity.

FAFP Policy on Privacy and Confidentiality that Relates to Internet CME Activities
FAFP is the sole owner of the information collected and presented on this site and FAFP does not sell, share, or rent users’ personally identifiable information to any third party. FAFP does share any anonymous or demographic information to any outside parties.


Contact Information/Inquiries:
Questions? Please contact Ashleigh Huff, FAFP Director of Membership and Workforce Development at (904) 726-0944 or via email at ahuff@fafp.org